对于将切断迷走神经用于治疗慢性阻塞性肺疾病的不同意见_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

 何权瀛

北京大学人民医院呼吸科（北京 100083）;

Corresponding author：

何权瀛, Email: hxk313@126.com

Keywords：

DOI：

10.7507/1671-6205.202204067

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 何权瀛. 对于将切断迷走神经用于治疗慢性阻塞性肺疾病的不同意见. Chinese Journal of Respiratory and Critical Care Medicine, 2022, 21(7): 457-458. doi: 10.7507/1671-6205.202204067 Copy

1.	黄永康, 张文宇, 黄建安. 靶肺去神经疗法在慢性阻塞性肺疾病中的应用进展. 中国呼吸与危重监护杂志, 2021, 20(11): 821-823.
2.	Valipour A, Asadi S, Pison C, et al. Long-term safety of bilateral targeted lung denervation in patients with COPD. Int J Chron Obstruct Pulmon Dis, 2018, 13: 2163-2172.
3.	Slebos DJ, Klooster K, Koegelenberg CF, et al. Targeted lung denervation for moderate to severe COPD: a pilot study. Thorax, 2015, 70(5): 411-419.
4.	Valipour A, Shah PL, Pison C, et al. Safety and dose study of targeted lung denervation in moderate/severe COPD patients. Respiration, 2019, 98(4): 329-339.
5.	Slebos DJ, Shah PL, Herth FJF, et al. Safety and adverse events after targeted lung denervation for symptomatic moderate to severe chronic obstructive pulmonary disease (AIRFLOW). A multicenter randomized controlled clinical trial. Am J Respir Crit Care Med, 2019, 200(12): 1477-1486.
6.	李为民, 刘伦旭. 呼吸系统疾病基础与临床. 北京: 人民卫生出版社, 2017, 11.
7.	Kistemaker LE, Slebos DJ, Meurs H, et al. Anti-inflammatory effects of targeted lung denervation in patients with COPD. Eur Respir J, 2015, 46(5): 1489-1492.

1. 黄永康, 张文宇, 黄建安. 靶肺去神经疗法在慢性阻塞性肺疾病中的应用进展. 中国呼吸与危重监护杂志, 2021, 20(11): 821-823.
2. Valipour A, Asadi S, Pison C, et al. Long-term safety of bilateral targeted lung denervation in patients with COPD. Int J Chron Obstruct Pulmon Dis, 2018, 13: 2163-2172.
3. Slebos DJ, Klooster K, Koegelenberg CF, et al. Targeted lung denervation for moderate to severe COPD: a pilot study. Thorax, 2015, 70(5): 411-419.
4. Valipour A, Shah PL, Pison C, et al. Safety and dose study of targeted lung denervation in moderate/severe COPD patients. Respiration, 2019, 98(4): 329-339.
5. Slebos DJ, Shah PL, Herth FJF, et al. Safety and adverse events after targeted lung denervation for symptomatic moderate to severe chronic obstructive pulmonary disease (AIRFLOW). A multicenter randomized controlled clinical trial. Am J Respir Crit Care Med, 2019, 200(12): 1477-1486.
6. 李为民, 刘伦旭. 呼吸系统疾病基础与临床. 北京: 人民卫生出版社, 2017, 11.
7. Kistemaker LE, Slebos DJ, Meurs H, et al. Anti-inflammatory effects of targeted lung denervation in patients with COPD. Eur Respir J, 2015, 46(5): 1489-1492.

Next Article
Inflammatory markers of oropharynx in the stable phase of chronic obstructive pulmonary disease

Chinese Journal of Respiratory and Critical Care Medicine

对于将切断迷走神经用于治疗慢性阻塞性肺疾病的不同意见

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content